latory sites on the NMDA receptor complex regulate channel activity. Glycine, acting at a strychnine-insensitive glycine binding site, enhances receptor activation and is necessary for maximal activity (Johnson and Ascher, 1987; Kleckner and Dingledine, 1988) . The dissociative anesthetics ketamine, phencyclidine (PCP), and (+)-5-methyl-10, I l-dihydro-5H-dibenzo- [a,d] cyclohepten-5, lo-imine maleate (MK-80 1 ; dizocilpine maleate) are noncompetitive antagonists of the NMDA receptor that bind to the so-called PCP site within the ion channel and prevent the passage of Na+ and Ca2+ through the channel (Anis et al., 1983; Honey et al., 1985; Reynolds et al., 1987; Wong et al., 1987) . Finally, Zn2+ and polyamines, acting at separate sites, also modulate NMDA receptor activity (Peters et al., 1987; Westbrook and Mayer, 1987; Ransom and Stec, 1988; Miller, 1988a,b, 1989; Christine and Choi, 1990) .
Although NMDA receptors have been classified as a homogeneous population of receptors, some studies indicate the existence of subtypes of the NMDA receptor (Perkins and Stone, 1983; Maragos et al., 1988; Monaghan et al., 1988; Honor6 et al., 1989; McDonald et al., 1990 ). Electrophysiological and radioligand binding studies indicate that one population of NMDA receptors, localized in the hindbrain and cerebellum, is insensitive to quinolinate, whereas quinoh a t e effectively depolarizes and potently displaces binding to forebrain NMDA receptors (Perkins and Stone, 1983; Stone and Burton, 1988; Monaghan and Beaton, 199 1) . Receptor binding studies using ligands that label the PCP site have revealed low-affinity PCP binding sites in the cerebellum (Vignon et al., 1986; Ebert et al., 199 1) . Throughout the forebrain the ratio of glycine to NMDA and PCP binding sites vanes between brain structures (McDonald et al., 1990) . A striking example of variant stoichiometry among NMDA, PCP, and glycine binding sites is found in the cerebellar granule cell layer, where the density of NMDA and glycine binding sites is relatively high but that of PCP binding sites is low (Maragos et al., 1988; Young and Fagg, 1990) . The presence of a unique NMDA receptor subtype in the cerebellum is supported by the recent discovery of an NMDA receptor RNA that is localized specifically in the cerebellum and not in the forebrain (Kutsuwada et al., 1992; Monyer et al., 1992) . Monaghan et al. (1988) have proposed the existence of agonist-and antagonist-preferring forms of the NMDA receptor based on binding studies using [3H] (Young and Fagg, 1990) . To determine if regional differences in NMDA receptor pharmacology exist in rat CNS, we have investigated the effects of differential activation of the NMDA receptor on quantitative autoradiographic [3H]MK-80 1 binding.
EXPERIMENTAL PROCEDURES

Tissue preparation
Male Sprague-Dawley rats (weighing 175-250 g; Charles River) were decapitated, and brains were removed rapidly, coated with Lipshaw embedding matrix, mounted on microtome chucks, and frozen under powdered dry ice. Horizontal sections 20 pm thick were cut on a Lipshaw cryostat and thaw-mounted onto gelatin-coated slides. Sections were stored at -20°C for <24 h.
Autoradiography
A detailed description of the method for quantitative autoradiography of [ 3H]MK-80 1 binding has been published (Sakurai et al., 1991) . In brief, tissue sections were prewashed in 50 mMTris-acetate buffer (pH 7.4) for 30 min at 4°C and blown-dry under a stream of cool air before the [3H]MK-80 1 binding assay was performed. In all experiments, quadruplicate tissue sections were incubated for 2 or 4 h in 50 mM Tris-acetate (pH 7.4) at room temperature containing 5 nM [3H]MK-801 at a final volume of 10 ml. Nonspecific binding was determined in the presence of 5 ~k l unlabeled MK-801. For control conditions in CPP competition studies, tissue sections were incubated with CPP in the presence of 1 pM glycine. In separate experiments assessing CPP inhibition of [3H]MK-80 1 binding under maximal stimulated conditions, glutamate (3 p M ) was included in the incubation mixture containing CPP and 1 pLM glycine. For control conditions in 7-chlorokynurenic acid (7-CIKyn) competition studies, tissue sections were incubated with 7-ClKyn in the presence of 3 pMglutamate. In separate experiments, glycine (1 p M ) was present in the incubation mixture containing 7-CIKyn and glutamate (3 N M ) .
Following the incubation, sections were dipped quickly into 50 mM Tris-acetate buffer (pH 7.4) at 4"C, rinsed in 250 ml of cold buffer for 80 min, and blown-dry under a stream of warm air. Dried tissue sections were placed in x-ray cassettes with appropriate radioactive standards and apposed to Hyperfilm (Amersham). Following a 3-4-week exposure period at 4"C, films were developed in D-19 (Kodak), fixed, and dried. All data presented were analyzed from resultant autoradiograms using computer-assisted image analysis (Imaging Research, Inc., St. Catharines, Ontario, Canada). Optical densities from autoradiograms were converted to binding densities using a polynomial regression curve derived from the calibrated radioactive standards. Ten to 20 readings per brain area from each of the quadruplicate sections were analyzed. (Sakurai et al., 199 1 
RESULTS
CPP inhibition of [3H]MK-801 binding (2-h incubation)
Under control conditions (no added glutamate, 1 pMglycine), equilibrium was reached at 100 min and remained stable for up to 6 h. The addition of as much as 100 pM glutamate and 30 pM glycine did not increase binding above control conditions and did not accelerate association. Under control conditions, CPP inhibited ['HIMK-80 1 binding in a regionally distinct manner (Table 1) In the presence of added glutamate ( 3 p M ) , the CPP displacement curves for [3H]MK-80 1 binding shifted rightward (Fig. 1) . The apparent K, values between regions maintained a similar relationship with the exception of OC, where the apparent K, value increased 2.5 times more than that in the other areas (Table 1 ). In the presence ofadded glutamate (3 pM), CPP inhibition of [3H]MK-80 1 binding in MC (6.5 t_ 1.6 p M ) 
CPP inhibition of [3H]MK-801 binding (4-h incubation)
In addition to the standard 2-h incubation period, CPP inhibition of [3H]MK-80 1 binding under control conditions (presence of 1 pMglycine) and under stimulated conditions (presence of 1 pM glycine and 3 pLM glutamate) was examined using a 4-h incubation.
CPP displacement curves for [3H]MK-80 1 binding following a 4-h incubation were shifted (five-to eightfold) to the right of CPP displacement curves obtained from 2-h incubations (Fig. 3) Fig. 4 and Table 3 ). Hill coefficients ranged from 1.7 to 2.9 and were all significantly > I ( p < 0.0001).
In the presence of added glycine (1 p M ) Figure 5 shows representative autoradiograms of 7-ClKyn inhibition of [3H]MK-80 1 binding in rat brain.
DISCUSSION
To assess the distribution and modulation of the NMDA receptor channel, [3H]MK-80 I binding was used to label NMDA receptors in rat brain sections under conditions that differentially activated the receptor. In well-washed homogenate preparations, [3H]MK-801 binding to the PCP site within the ion channel is highly regulated by glutamate and glycine, and the presence of both is necessary to measure binding (Bonhaus and McNamara, 1988; Kloog et al., 1988a,6; Javitt and Zukin, 1989a,b) . NMDA and glycine antagonists, such as CPP and 7-C1Kyn, respectively, inhibit [.3H]MK-80 1 binding (Foster and Wong, 1987; Kloog et al., 1988a,b; Ransom and Stec, 1988; Sircar et al., 1989; Sakurai et al., 199 1) . Following our standard prewash, enough endogenous glutamate and glycine are present in the tissue sections to activate NMDA receptors and allow [3H]MK-80 1 to bind specifically (Sakurai et al., 1991 The presence of glutamate and glycine enhances NMDA receptor activity and increases the association rate of [3H]MK-80 1, but CPP slows the rate of association (Kloog et al., 1988a,b) . We have demonstrated previously that in our autoradiographic assay [3H]-MK-80 1 binding is at equilibrium by 2 h (Sakurai et al., 1991 (Hosford et al., 1990) . Glutamate and glycine antagonists may slow the association rate of [3H]MK-80 1 binding and thereby artificially result in high Hill coefficients (Sakurai et al., 1991) . In the present study under control conditions, the apparent Hill coefficients were not significantly different than 1 for CPP inhibition of Alternatively, the presence of added glutamate and glycine may reveal more than one population of binding sites, which would also be reflected in Hill coefficients of > 1. The allosteric interaction between sites also may be altered under conditions that differentially activate the NMDA receptor complex, thereby resulting in higher Hill coefficients.
On the basis of our study, it appears that regional heterogeneity of NMDA receptor pharmacology can be demonstrated by NMDA agonist site and strychnine-insensitive glycine binding site regulation of [3H]MK-80 1 binding in rat forebrain. One population of NMDA receptors, distributed in the MC, exhibited a higher affinity for CPP than in the outer cortical layers. Another population of NMDA receptor subtypes in MT and LT had a slightly lower affinity for CPP, whereas NMDA receptors distributed in the MS and LS as well as in the DG and CA 1 region of the hippocampus exhibited the lowest affinity for CPP. Regulation of the NMDA receptor complex at the strychnine-insensitive glycine binding site revealed the presence of at least two populations of NMDA receptors. One population of receptors, distributed in the OC and MC and the LS and MS, had a higher affinity for the glycine antagonist 7-ClKyn than NMDA receptors distributed in the MT and LT and the DG and CAI region of the hippocampus.
The results of our study suggest that the regional heterogeneity of [3H]MK-80 1 binding in rat forebrain under certain conditions may be due to the presence of at least two or more subtypes of the NMDA receptors that are differentially regulated by the glutamate and glycine binding sites. Alternatively, two or three receptor subtypes may be expressed in different proportions within a region, resulting in heterogeneity of [3H]MK-80 1 binding under any given conditions. Our study focused on the forebrain because under our standard assay conditions, [3H]MK-80 1 binding is not present in the cerebellum (Sakurai et al., 1991) . Electrophysiological and binding studies suggest, however, that a pharmacologically distinct NMDA receptor is present in the cerebellum (Perkins and Stone, 1983; Stone and Burton, 1988; Monaghan and Beaton, 1991) .
The heterogeneity of [3H]MK-80 1 binding under conditions that differentially activate the NMDA receptor in the forebrain may be due to the regionally specific expression of different NMDA receptor proteins. Now that the NMDA receptor has been cloned (Kumaretal., 1991; Moriyoshietal., 1991) , characterization of the heterogeneity of the NMDA receptor at the molecular level will be possible. In fact, Nakanishi and co-workers have reported discrepancies between the distribution of NMDA receptor ligand binding sites and NMDA receptor mRNA expression sites, which may reflect the presence of multiple NMDA receptor subtypes (Moriyoshi et al., 199 1) . More recently, three additional NMDA receptor subunits have been cloned (Meguro et al., 1992; Monyer et al., 1992) . These subunits are expressed selectively throughout the brain, and different combinations of these subunits exhibit functional diversity when characterized electrophysiologically (Meguro et al., 1992; Monyer et al., 1992) . The molecular diversity of the NMDA receptor subunits and the posttranslational processing of receptor proteins are likely to contribute to the pharmacological heterogeneity of the NMDA receptor complex.
